2003D-0206 - Draft Guidance for Industry on Exocrine Pancreatic Insufficiency Drug Products--Submitting New Drug Application; Availability
FDA Comment Number : EC16
Submitter : Ms. Subha Indrarajah Date & Time: 07/12/2004 12:07:34
Organization : CanReg Inc. on behalf of Axcan Scandipharm Inc.
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
RE: Docket No. 2003D-0206, CDER 200275 (Draft) Guidance for Industry Exocrine Pancreatic Insufficiency Drug Products ? Submitting NDAs, Federal Register, Vol. 69, April 28, 2004 [FR Doc. 04-09653]